Short interest in Ovid Therapeutics Inc (NASDAQ:OVID) decreased during the last reporting period, falling from 756.53K to 740.28K. This put 1.26% of the company's publicly available shares short.

Short interest for Ovid Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Ovid Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 202.31K shares traded per day, it would take 3.66 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.